BHRT pellets, creams, and patches are different ways to deliver hormones into the body. Pellets are inserted under the skin and release hormone slowly over several months. Creams are applied to the skin and can be adjusted more easily. Patches stick to the skin and provide a steady transdermal dose, most commonly for estradiol. None of these options is automatically best for everyone. The right choice depends on which hormone is being used, your symptoms, safety risks, dose flexibility needs, lifestyle, absorption, side effects, cost, and how closely you need to be monitored.
Key Points
- Pellets are convenient but less adjustable. Pellets can last for months, which is helpful for people who do not want daily dosing. The downside is that the dose cannot be easily lowered once inserted.
- Creams are flexible but require consistency. Hormone creams can be adjusted more easily than pellets, but they must be applied correctly and consistently. Some topical hormones can transfer to partners, children, or pets if precautions are not followed.
- Patches are steady and adjustable. Estradiol patches are commonly used because they provide transdermal estrogen and allow dose changes when needed. Skin irritation or adhesion problems can occur for some people.
- Route affects safety. Transdermal estradiol, such as patches, gels, and some creams, avoids first-pass liver metabolism and may be preferred for some patients based on clotting, triglyceride, migraine, or cardiovascular risk factors.
- Pellets are most often used for testosterone. Testosterone pellets may be used in some men with confirmed testosterone deficiency and in select women with careful dosing. Women should not be dosed like men.
- Compounded and FDA-approved options are different. Some patches, gels, and capsules are FDA-approved. Some creams and pellets may be compounded. Compounded therapy can be useful, but the final compounded formulation is not reviewed by FDA in the same way as a commercially manufactured drug.
- Monitoring matters with every route. BHRT should include symptom tracking, side effect review, lab monitoring when appropriate, and regular reassessment of dose, route, risks, and benefits.
Understanding BHRT Delivery Options
BHRT stands for bioidentical hormone replacement therapy. It uses hormones that are chemically identical to hormones the body naturally makes, such as estradiol, progesterone, and testosterone.
The hormone molecule matters, but the delivery route matters too. The same hormone can behave differently depending on whether it is delivered through the skin, swallowed, injected, placed under the skin, or used locally in vaginal tissue.
Pellets, creams, and patches are all hormone delivery methods. They are not interchangeable, and each has strengths and tradeoffs. A pellet may be convenient but hard to adjust. A cream may be flexible but requires careful application. A patch may provide steady estradiol but may irritate the skin.
The best option depends on the goal. A woman treating hot flashes may do well with an estradiol patch. A woman needing vaginal comfort may need local vaginal estrogen rather than systemic therapy. A man with confirmed testosterone deficiency may prefer injections, gels, or pellets depending on his goals and monitoring plan. A woman with low sexual desire may need a very conservative testosterone dose that is easier to adjust than a pellet.
A responsible hormone plan starts with the question: Which hormone is needed, why is it needed, and which route is safest and most practical for this person?
BHRT Pellets: Pros And Cons
Pellets are small hormone-containing implants placed under the skin, usually in the upper buttock or hip area. They slowly release hormone over several months.
The main advantage of pellets is convenience. Once inserted, there is no daily application, no patch to replace, and no pill to remember. This can be appealing for people who travel often, forget daily medication, or prefer a long-acting option.
Pellets may also provide a steady release for some patients. This can be helpful for people who experience noticeable ups and downs with shorter-acting hormone methods.
The main disadvantage is limited dose flexibility. Once a pellet is inserted, the dose cannot be easily lowered or stopped. If the dose is too high, side effects may continue until the pellet wears down. If the dose is too low, symptom relief may be incomplete until the next adjustment window.
Pellets also require a minor in-office procedure. Possible procedure-related side effects include bruising, soreness, bleeding, infection, scarring, tenderness, or pellet extrusion. These are not common for everyone, but they should be discussed before treatment.
Pellets are most commonly used for testosterone. Testosterone pellets require careful monitoring because excessive levels can cause acne, oily skin, unwanted hair growth, scalp hair thinning, irritability, sleep changes, elevated red blood cell count in men, and fertility suppression in men. In women, dosing must be especially conservative.
BHRT Creams: Pros And Cons
Hormone creams are applied to the skin, where the hormone is absorbed through the skin into the bloodstream or into local tissue depending on the formulation and application site.
The main advantage of creams is dose flexibility. If symptoms improve but side effects appear, the dose can often be adjusted more easily than a pellet. This can be helpful for people who are sensitive to hormone changes or just starting therapy.
Creams can also be customized in certain cases. A compounding pharmacy may prepare a specific dose, combination, or base when a commercially available product does not fit the patient’s needs. This may be useful for low-dose testosterone, certain progesterone preparations, or individualized formulations.
The downside is consistency. Creams must be applied correctly, usually at the same time each day, and absorption can vary based on skin site, skin thickness, sweating, bathing, lotions, and individual metabolism.
Another important concern is transfer. Some topical hormones, especially testosterone, can transfer to partners, children, or pets through skin contact if the application site is not covered or if hands are not washed after use. This can cause unintended hormone exposure.
Creams may also cause skin irritation, odor, residue, inconsistent absorption, or confusion about dosing if instructions are not clear. Patients should know exactly where to apply the cream, how much to use, when to apply it, and how to prevent transfer.
BHRT Patches: Pros And Cons
Hormone patches are applied to the skin and release medication gradually. Estradiol patches are one of the most common transdermal BHRT options for menopause symptoms.
The main advantage of patches is steady, adjustable dosing. Patches come in standardized strengths and can usually be changed more easily than pellets. This makes them useful when treating hot flashes, night sweats, sleep disruption, and other estrogen-related symptoms.
Transdermal estradiol avoids first-pass liver metabolism, meaning it does not pass through the liver first in the same way oral estrogen does. For some patients, this route may be preferred based on clotting risk, triglycerides, migraines, blood pressure, or cardiovascular risk profile.
Patches are also FDA-approved in many estradiol formulations, which means the dose and manufacturing are standardized. This can make prescribing, monitoring, and insurance coverage more straightforward for some patients.
The downsides are mostly practical. Patches can irritate the skin, fall off, leave adhesive residue, or be visible depending on clothing and placement. Some people are sensitive to patch adhesives.
Patches are most commonly used for estradiol, not progesterone or testosterone. If a woman uses systemic estrogen and has a uterus, she usually still needs progesterone or another appropriate progestogen to protect the uterine lining.
Which Option Is Best For Estradiol?
For many women using systemic estrogen, an estradiol patch is often a strong first option because it is standardized, steady, adjustable, and transdermal.
Estradiol creams and gels may also be appropriate, especially for patients who prefer topical application or need a different dosing style. These can be FDA-approved or compounded depending on the product.
Estradiol pellets are used by some practices, but they are less flexible. Because estradiol needs may change over time and side effects such as breast tenderness, headaches, fluid retention, mood changes, or bleeding patterns may require adjustment, many patients benefit from a route that can be changed more easily.
Local vaginal estrogen is different from systemic estrogen. It is used primarily for vaginal dryness, painful sex, urinary urgency, recurrent urinary discomfort, and tissue thinning. For some patients, local therapy may be enough even when systemic estrogen is not needed.
The best estradiol route depends on symptoms, uterus status, clotting risk, cardiovascular risk, migraine history, liver health, preference, cost, and how much dose flexibility is needed.
Which Option Is Best For Progesterone?
Progesterone is usually discussed differently than estradiol because its role depends heavily on whether the uterus is present and whether systemic estrogen is being used.
If systemic estrogen is used and the uterus is present, progesterone or another appropriate progestogen is usually needed to protect the uterine lining. Without enough uterine protection, estrogen can stimulate the lining and increase the risk of abnormal thickening.
Oral micronized progesterone is a common bioidentical option. It is often taken at bedtime because it may cause sleepiness and may support sleep for some patients.
Progesterone creams are used by some practices, but absorption and uterine protection can be more variable depending on the dose and formulation. If progesterone is being used specifically to protect the uterine lining, the route and dose should be chosen carefully.
Progesterone pellets are not commonly used as a standard first-line option. Progesterone decisions should be individualized based on symptoms, uterus status, estrogen dose, bleeding pattern, side effects, and safety monitoring.
Progestins are synthetic progesterone-like medications, while micronized progesterone is bioidentical to the progesterone the body naturally makes. These can have different effects and different risk profiles, so patients should know exactly which one they are taking.
Which Option Is Best For Testosterone?
Testosterone can be delivered by gels, creams, injections, or pellets, depending on the patient and clinical situation.
For men with confirmed testosterone deficiency, pellets may be an option when the patient wants a long-acting method and understands the monitoring requirements. Injections, gels, and creams may offer more dose control depending on the situation.
For women, testosterone dosing should be much lower than male dosing. Many clinicians prefer adjustable methods such as low-dose creams or gels because they allow more careful titration. Pellets may be less ideal for women who are new to testosterone therapy or sensitive to androgen side effects.
Testosterone may be considered for select women with persistent low sexual desire that causes distress after other causes have been evaluated. It should not be used casually for fatigue, weight loss, or anti-aging.
Possible signs of excess testosterone include acne, oily skin, unwanted facial or body hair, scalp hair thinning, irritability, mood changes, sleep disruption, voice changes, or clitoral enlargement in women. In men, excess or poorly monitored therapy can increase red blood cell count, worsen sleep apnea, affect fertility, and require prostate-related monitoring when appropriate.
FDA-Approved Versus Compounded Options
Bioidentical hormones can be available as FDA-approved medications or as compounded prescriptions. Bioidentical describes the hormone molecule itself, not whether the medication is commercial or compounded.
Many estradiol patches, gels, sprays, vaginal products, and oral micronized progesterone capsules are FDA-approved bioidentical options. These products have standardized dosing, labeling, and manufacturing oversight.
Compounded BHRT may be used when a patient needs a customized dose, route, combination, or formulation that is not commercially available. This may include certain creams, capsules, troches, vaginal preparations, or testosterone formulations.
Estradiol, progesterone, and testosterone can exist as FDA-approved medications or as ingredients used in compounded prescriptions. The final compounded formulation is customized and is not reviewed by FDA in the same way as a commercially manufactured drug.
Compounded therapy can be appropriate in selected cases, but it should not be assumed to be safer or better simply because it is customized. Pharmacy quality, dosing accuracy, route, and monitoring matter.
How It Works / What’s Involved
Choosing between pellets, creams, and patches starts with a full hormone evaluation. Your provider should review symptoms, menopause stage, menstrual pattern, sleep, mood, libido, hot flashes, night sweats, vaginal or urinary symptoms, medical history, medications, supplements, cancer history, clotting history, migraines, heart health, and treatment goals.
Testing may include estradiol, progesterone, total and free testosterone, SHBG, DHEA-S, FSH, LH, thyroid markers, CBC, CMP, fasting glucose, fasting insulin, A1C, lipids, ferritin, vitamin D, and other labs depending on symptoms and history.
The provider should then match the hormone and route to the clinical goal. For example, an estradiol patch may be chosen for hot flashes and sleep disruption. Local vaginal estrogen may be chosen for painful sex or urinary symptoms. A low-dose testosterone cream may be chosen for select women with low sexual desire. A testosterone pellet may be considered for a man with confirmed testosterone deficiency who wants long-acting therapy.
Follow-up should include symptom tracking, side effect review, bleeding pattern, breast symptoms, skin changes, hair changes, mood, sleep, libido, blood pressure, and labs when appropriate.
The route can change over time. A person may start with a patch and later switch to a cream, or start with a cream before considering pellets. The plan should be responsive rather than locked in.
Who It’s For And Who Should Be Cautious
Pellets may be appropriate for people who have a clear hormone need, tolerate the hormone well, prefer long-acting therapy, and understand that dose changes are limited after insertion.
Creams may be appropriate for people who need flexible dosing, customized strengths, or gradual titration. They require consistent application and transfer precautions, especially with testosterone.
Patches may be appropriate for women using estradiol for menopause symptoms who want a standardized, steady, adjustable, transdermal option.
People who should be cautious with systemic hormone therapy include those with unexplained bleeding, bleeding after menopause, active or recent blood clots, clotting disorders, certain hormone-sensitive cancers, severe liver disease, pregnancy, uncontrolled blood pressure, high cardiovascular risk, migraines with aura, severe mood symptoms, or complex medication histories.
People who should be cautious with pellets include those who are new to hormone therapy, sensitive to dose changes, prone to side effects, uncertain about dosing, or likely to need frequent adjustments.
Risks, Side Effects, and Monitoring
Pellet-related risks include bruising, soreness, bleeding, infection, scarring, tenderness, pellet extrusion, and prolonged side effects if the dose is too high.
Cream-related risks include inconsistent absorption, skin irritation, dosing errors, residue, and hormone transfer to others. Transfer risk is especially important with testosterone creams and gels.
Patch-related risks include skin irritation, adhesive reactions, patch detachment, residue, and dose issues if the patch does not stay on properly.
Estrogen side effects may include breast tenderness, bloating, headaches, nausea, fluid retention, mood changes, or spotting. Abnormal bleeding, heavy bleeding, persistent bleeding, or bleeding after menopause should be evaluated.
Progesterone may cause sleepiness, dizziness, mood changes, bloating, breast tenderness, vivid dreams, or changes in bleeding patterns. Testosterone side effects may include acne, oily skin, unwanted hair growth, scalp hair thinning, irritability, sleep disruption, libido changes, elevated levels, increased red blood cell count in men, and fertility suppression in men.
Monitoring should include symptom response, side effects, blood pressure, bleeding pattern, breast and pelvic symptoms, skin or insertion-site reactions, mood, sleep, libido, hair and acne changes, CBC, CMP, lipids, glucose and insulin markers, hormone levels when appropriate, and age-appropriate screening.
Safety
Seek urgent medical care right away for chest pain, severe shortness of breath, fainting, one-sided weakness or numbness, sudden severe headache, vision changes, severe leg swelling or calf pain, coughing blood, severe abdominal pain, suicidal thoughts, or confusion. These symptoms should not be treated as routine hormone side effects.
Call your provider for non-urgent but important concerns such as abnormal bleeding, bleeding after menopause, breast changes, pelvic pain, worsening headaches, mood changes, acne, unwanted hair growth, scalp hair thinning, voice changes, sleep disruption, skin irritation, patch reactions, cream transfer concerns, or redness, drainage, fever, or worsening pain at a pellet insertion site.
Do not choose a hormone route based only on convenience, online testimonials, or claims that one method is always best. Safe BHRT depends on the hormone, route, dose, symptoms, medical history, risk factors, pharmacy quality, and follow-up monitoring.
Sources and Citations
- The 2025 Menopausal Hormone Therapy Guidelines — PMC
- The 2022 Hormone Therapy Position Statement — Menopause / PubMed
- Hormone Replacement Therapy — NCBI Bookshelf
- Compounded Bioidentical Menopausal Hormone Therapy — American College of Obstetricians and Gynecologists
- Global Consensus Position Statement on the Use of Testosterone Therapy for Women — The Journal of Clinical Endocrinology & Metabolism / PubMed
- Testosterone Deficiency Guideline — American Urological Association
- Testosterone Therapy in Men With Hypogonadism — Endocrine Society

About the Author: Dr. Gretchen Reis



